University of Virginia Natural History Study
Launched by UNIVERSITY OF VIRGINIA · May 20, 2021
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Following the clinical course of patients with ILD will allow description of the natural history of these diseases and prospective analysis of the following specific questions:
1. Can surrogate physiological markers of disease progression be used in place of mortality? Mortality of a defined cohort of patients will be developed. The surrogate markers include but are not limited to serial cardiopulmonary exercise testing, pulmonary function testing, 6-minute walk testing, HRCT scanning and echocardiography.
2. Do alternative assessments such as quality of life (QOL) questionnaires provide e...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient presenting to University of Virginia ILD or Pulmonary clinic
- • Family members accompanying patients (as control subjects)
- Exclusion Criteria:
- • Control subjects cannot have ILD
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Patients applied
Trial Officials
Imre Noth, MD
Principal Investigator
University of Virginia Health System
Yousef Althulth, MD
Study Director
University of Virginia Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials